Wednesday, February 10, 2010, 1:52PM AEST - The Australian Stockmarket closes in 2 hours and 13 minutes.
To create a watchlist or portfolio of shares, Register

Smith & Nephew plc (SNN)

 8:04AM AEST: 50.24 USD  Up 1.14 (2.32%)  
 MORE ON SNN 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 SMITH&NEPHEW PLC NEW (NYSE:SNN) Delayed quote dataEdit
Last Trade:50.24 USD
Trade Time: 8:04AM AEST
Change:Up 1.14 (2.32%)
Prev Close:49.10
Open:49.65
Bid:N/A
Ask:N/A
1y Target Est:48.67
Day's Range:49.36 - 50.47
52wk Range:30.01 - 53.66
Volume:124,755
Avg Vol (3m):86,725.4
Market Cap:8.87B
P/E (ttm):19.32
EPS (ttm):2.60
Div & Yield:0.68 (1.38%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add SNN to Portfolio   Download Data

 HEADLINES 
•Conmed Surpasses Zacks Estimate
Zacks.com (Tue 1:43AM)
•Smith & Nephew upgraded by UBS
Briefing.com (Mon, Feb 8)
•The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in Hamburg
PR Newswire (Wed, Feb 3)
•International NPWT Expert Panel Convenes in Hamburg
PR Newswire (Wed, Feb 3)
•Smith & Nephew Endoscopy Awarded Contract From Healthtrust Purchasing Group
PR Newswire (Tue, Feb 2)
•2010 Recovery In Capital Expenditures By Hospitals Will Benefit Specific Medical Equipment Sectors According To 14 Year Industry Veteran
Wall Street Transcript (Tue, Jan 26)
•More British Stocks To Consider
at Investopedia (Mon, Jan 25)
•Smith & Nephew donates medical equipment to Haiti
AP (Thu, Jan 21)
•Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
PR Newswire (Thu, Jan 21)
•Stryker Reports Preliminary Results
Zacks.com (Fri, Jan 15)
•Stryker Completes Acquisition
Zacks.com (Tue, Jan 5)
•Relocation Cost for Wright
Zacks.com (Wed, Dec 30)
•Smith & Nephew completes purchase of Nucryst
AP (Wed, Dec 23)
•Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.
PR Newswire (Wed, Dec 23)
More Headlines for SNN...
 ANALYST 
EPS Est (next year) (Dec-09) :2.92
EPS Est (in 2 years) (Dec-10) :3.35
Avg Rec (current)*:3.2
PEG Ratio:1.64
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, marketing, and sale of medical devices worldwide. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices